Insmed
INSM
#744
Rank
C$46.41 B
Marketcap
C$217.63
Share price
-0.15%
Change (1 day)
91.35%
Change (1 year)

Market capitalization of Insmed (INSM)

Market cap: C$46.41 Billion

As of February 2026 Insmed has a market cap of C$46.41 Billion. This makes Insmed the world's 744th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insmed from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026C$46.41 B-10.66%
2025C$51.95 B190.72%
2024C$17.87 B203.9%
2023C$5.88 B60.1%
2022C$3.67 B-10.62%
2021C$4.10 B-4.96%
2020C$4.32 B54.59%
2019C$2.79 B102.45%
2018C$1.38 B-53.98%
2017C$3.00 B172.92%
2016C$1.10 B-29.31%
2015C$1.55 B74.06%
2014C$0.89 B26.25%
2013C$0.70 B238.11%
2012C$0.20 B171.89%
2011C$77.04 M-21.94%
2010C$98.7 M-6.44%
2009C$0.10 B51.73%
2008C$69.52 M-30.7%
2007C$0.10 B-3.36%
2006C$0.10 B-31.96%
2005C$0.15 B28.68%
2004C$0.11 B-19.84%
2003C$0.14 B528.55%
2002C$23.53 M-88.26%
2001C$0.20 B17.57%
2000C$0.17 B

End of Day market cap according to different sources

On Feb 23rd, 2026 the market cap of Insmed was reported to be:

C$46.98 Billion
by Nasdaq info icon info icon
C$46.48 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
C$442.53 B 853.44%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
C$250.64 B 440.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$169.67 B 265.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$2.73 B-94.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C$1.03 B-97.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
C$2.26 B-95.12%๐Ÿ‡บ๐Ÿ‡ธ USA